Accès à distance ? S'identifier sur le proxy UCLouvain
Clinical trials in severe sepsis with drotrecogin alfa (activated).
Primary tabs
- Open access
- 100.61 K
Document type | Article de périodique (Journal article) – Journal Article, Review |
---|---|
Access type | Accès libre |
Publication date | 2007 |
Journal information | "Critical care (London, England)" - Vol. 11 Suppl 5, p. S5 (2007) |
Peer reviewed | yes |
e-issn | 1466-609X |
issn | 1364-8535 |
Publication status | Publié |
Affiliation | UCL - MD/MINT - Département de médecine interne |
MESH Subject | APACHE ; Adult ; Anti-Infective Agents - adverse effects - therapeutic use ; Child ; Clinical Trials as Topic ; Clinical Trials, Phase I as Topic ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Clinical Trials, Phase IV as Topic ; Drug Administration Routes ; Drug Administration Schedule ; Hemorrhage - chemically induced ; Humans ; Multicenter Studies as Topic ; Product Surveillance, Postmarketing ; Protein C - adverse effects - therapeutic use ; Recombinant Proteins - adverse effects - blood - therapeutic use ; Research Design ; Sepsis - blood - drug therapy - mortality ; Survival Rate |
Links |
Bibliographic reference | Laterre, Pierre-François. Clinical trials in severe sepsis with drotrecogin alfa (activated).. In: Critical care (London, England), Vol. 11 Suppl 5, p. S5 (2007) |
---|---|
Permanent URL | http://hdl.handle.net/2078.1/11288 |